Trial Profile
Clinical Trials Insight: 700051367
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 25 Nov 2009
Price :
$35
*
At a glance
- Drugs DAC 0060 (Primary)
- Indications Skin cancer
- Focus Adverse reactions
- Sponsors DAC Research
- 25 Nov 2009 New trial record.